Book I: Combating communicable diseases

Art. D. 3112-8 -I.-The application for authorisation shall be sent by the head of the managing body to the Director General of the Regional Health Agency for the region in which the centre is located. The list of documents to be provided in support of the application is defined by order of the Minister for Health. This application specifies the methods of organisation and operation of the centre, in particular…

If the Director General of the Regional Health Agency does not respond to an application for authorisation or an application for renewal of authorisation, as referred to in I and III of Article D. 3112-8 respectively, this will be deemed to constitute acceptance of the application on expiry of a period of four months from the date of receipt of the complete application.

The Regional Health Agency is responsible for the strategic planning, coordination, monitoring and analysis of the activities of approved centres. The tuberculosis centres approved under the conditions of article D. 3112-8 must submit an activity and performance report for the previous year to the Director General of the Regional Health Agency before 31st March each year, in accordance with a model laid down by order of the Minister for Health.

The anti-tuberculosis centre shall inform the Director General of the Regional Health Agency of any changes to the organisational and operational procedures set out in the application for authorisation. When it has been established in the presence of both parties that the centre’s operational procedures no longer meet the conditions laid down in Articles D. 3112-7 to D. 3112-8, the Director General of the Regional Health Agency shall give formal…

Each year, the Director General of the Regional Health Agency sends the Minister for Health and the State representative in the département an updated list of the tuberculosis centres approved in application of this section.

Expenses relating to the activities of tuberculosis centres covered under III of article L. 3112-2 include : 1° Medical, paramedical and social worker consultations; 2° Biological, bacteriological, serological, biochemical and radiological investigations, as well as intradermal tuberculin tests; 3° Medicines required for the outpatient treatment of latent tuberculosis infections and tuberculosis disease, as well as the health products required for vaccinations and any serious adverse reactions; 4° Expenditure relating to…

The amount of the fixed annual grant referred to inArticle L. 174-16 of the Social Security Code is determined by an agreement signed by the centre’s representative and the Director General of the Regional Health Agency before the end of the first quarter of the year for which the grant applies. In the absence of an agreement between the Director General of the Regional Health Agency and the representative of…

The annual lump-sum grant referred to inarticle L. 174-16 of the Social Security Code is set, in compliance with the credit amounts defined inarticle R. 1435-25 of the Public Health Code, taking into account in particular: 1° The scope of activity expenditure defined in article D. 3112-11-2 of this Code; 2° The centre’s activity over the last three years. When the centre has been in operation for less than three…